SCOPUS 정보 검색 플랫폼

Cancer Immunology Immunotherapy

Volumn 45, Issue 3-4, 1997, Pages 184-186

Treatment of refractory Hodgkin's disease with an anti-CD16/CD30 bispecific antibody

(3) Renner, Cristoph a Hartmann, Frank a Pfreundschuh, Michael a

a SAARLAND UNIVERSITY (Germany)

Author keywords

Bispecific antibodies; Hodgkin's lymphoma; Natural killer cells

Indexed keywords

BISPECIFIC ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; DRUG SCREENING; DRUG TOLERABILITY; FEVER; HODGKIN DISEASE; HUMAN; LYMPHADENOPATHY; NATURAL KILLER CELL; PAIN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME;

ADULT; ANTIBODIES, BISPECIFIC; ANTIBODIES, MONOCLONAL; ANTIGENS, CD30; HODGKIN DISEASE; HUMANS; MIDDLE AGED; RECEPTORS, IGG;

EID: 0030813106 PISSN: 03407004 EISSN: None Source Type: Journal
DOI: 10.1007/s002620050428 Document Type: Article

Times cited : (25)

References (8)

1
- 0027531423
- Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant Interleukin 2
- Caligiuri MA, Murray C, Robertson MJ, Wang E, Cochran K, Cameron C, Schow P, Ross ME, Klumpp TR, Soiffer RJ, Smith KA, Ritz JA (1993) Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant Interleukin 2. J Clin Invest 91:123
- (1993) J Clin Invest , vol.91 , pp. 123
- Caligiuri, M.A.¹ Murray, C.² Robertson, M.J.³ Wang, E.⁴ Cochran, K.⁵ Cameron, C.⁶ Schow, P.⁷ Ross, M.E.⁸ Klumpp, T.R.⁹ Soiffer, R.J.¹⁰ Smith, K.A.¹¹ Ritz, J.A.¹²

2
- 0019379366
- The consequences of chemotherapy of Hodgkin's disease (1987) the 10th David A. Karnofsky Memorial Lecture
- DeVita VT (1987) The consequences of chemotherapy of Hodgkin's disease (1987) The 10th David A. Karnofsky Memorial Lecture. Cancer 47:1
- (1987) Cancer , vol.47 , pp. 1
- DeVita, V.T.¹

3
- 0027081036
- Bispecific antibodies
- Fanger MW, Morganelli PM, Guyre PM (1992) Bispecific antibodies. Crit Rev Immunol 12:101
- (1992) Crit Rev Immunol , vol.12 , pp. 101
- Fanger, M.W.¹ Morganelli, P.M.² Guyre, P.M.³

4
- 0027197493
- Diabodies. Small bivalent and bispecific antibody fragments
- Holliger P, Prospero T, Winter G (1993) Diabodies. Small bivalent and bispecific antibody fragments. Proc Natl Acad Sci USA 90:6444
- (1993) Proc Natl Acad Sci USA , vol.90 , pp. 6444
- Holliger, P.¹ Prospero, T.² Winter, G.³

5
- 4243680551
- A manual for participants in clinical trials of investigational agents
- Cancer therapy evaluation program, DCT, NCI, Bethesda, MD 20892, USA
- Investigator's handbook (1993) A manual for participants in clinical trials of investigational agents. Cancer therapy evaluation program, DCT, NCI, Bethesda, MD 20892, USA
- (1993) Investigator's Handbook

6
- 0020518331
- Hybrid hybridomas and their use in immunohislochemistry
- Milstein C, Cuello AC (1983) Hybrid hybridomas and their use in immunohislochemistry. Nature 305:537
- (1983) Nature , vol.305 , pp. 537
- Milstein, C.¹ Cuello, A.C.²

7
- 0028989969
- Tumor therapy by immune recruitment with bispecific antibodies
- Renner C, Pfreundschuh M (1995) Tumor therapy by immune recruitment with bispecific antibodies. Immunol Rev 145:179
- (1995) Immunol Rev , vol.145 , pp. 179
- Renner, C.¹ Pfreundschuh, M.²

8
- 0028822836
- Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erB-2 and FcγRIII
- Weiner LM, Clark JI, Davey M, Li WS, Palazzo IG de, Ring DB, Alpaugh RK (1995) Phase I trial of 2B1, a bispecific monoclonal antibody targeting c-erB-2 and FcγRIII. Cancer Res 55:4586
- (1995) Cancer Res , vol.55 , pp. 4586
- Weiner, L.M.¹ Clark, J.I.² Davey, M.³ Li, W.S.⁴ De Palazzo, I.G.⁵ Ring, D.B.⁶ Alpaugh, R.K.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.